Simmons v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedJanuary 2, 2024
Docket23-0121V
StatusUnpublished

This text of Simmons v. Secretary of Health and Human Services (Simmons v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Simmons v. Secretary of Health and Human Services, (uscfc 2024).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 23-121V Filed: December 7, 2023 Reissued for Public Availability: January 2, 2024

************************* * * DEBRA SIMMONS, * * * TO BE PUBLISHED Petitioner, * * v. * Special Master Katherine E. Oler * * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * * *************************

Debra Simmons, Eugene, OR, pro se Meghan Murphy, U.S. Department of Justice, Washington, DC, for Respondent

DECISION DISMISSING PETITION1

On January 27, 2023, Debra Simmons (“Petitioner” or “Ms. Simmons”) filed a petition for compensation under the National Vaccine Injury Compensation Program, 2 alleging that she developed Guillain-Barré syndrome (“GBS”), as a result of the influenza (“flu”) vaccination she received on November 12, 2019. ECF No. 1 (“Pet.”) at 1. For the reasons discussed in this decision, I find that the petition must be dismissed because it was filed more than 36 months after

1 Pursuant to Vaccine Rule 18(b), this decision was initially filed on December 7, 2023, and the parties were afforded 14 days to propose redactions. The parties did not propose any redactions. Accordingly, this decision is reissued in its original form for posting on the Court’s website. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Petitioner’s first symptom of GBS began, and Petitioner has not justified the tolling of the statute of limitations.

I. Procedural History

On January 27, 2023, Petitioner filed a pro se petition for compensation. Pet. I held an initial status conference with the parties on February 7, 2023, where I informed Ms. Simmons that her petition appears to have been filed out of time. ECF No. 11 at 1. I told Petitioner that I would “give her the opportunity to file additional evidence either (1) establishing a different timeline for her injury or (2) demonstrating why the doctrine of equitable tolling should apply in her case.” Id. I gave Petitioner 30 days to file all documentation relevant to the statute of limitations issue. Id. at 2.

On March 6, 2023, Petitioner filed her affidavit (“Pet. Aff.”) and three medical record exhibits (“Ex. 1,” “Ex. 2,” and “Ex. 3”). ECF No. 12. Each exhibit contains excerpts from medical records with some pages clearly missing. On March 28, 2023, I gave Respondent 60 days to file a memorandum stating his position on the statute of limitation issue. ECF No. 13.

On May 30, 2023, Respondent filed a memorandum arguing that Petitioner’s claim is barred by the statute of limitations and moving to dismiss the petition on that basis. ECF No. 14 (“Resp. Memo.”). On June 1, 2023, I gave Petitioner 60 days to file a response to the memorandum. ECF No. 15. Petitioner contacted my law clerk via email on June 14, 2023, with questions about her case. On June 23, 2023, I held another status conference with the parties at which Petitioner stated that, due to her condition, she had difficulty typing and that she would prefer to speak her response to the memorandum at a later status conference. ECF No. 17. I agreed to hold another status conference at which Petitioner would have the opportunity to speak her response to the motion to dismiss. Id.

On July 24, 2023, I held a recorded status conference where Petitioner delivered a spoken response to Respondent’s memorandum. Petitioner spoke for approximately 45 minutes and argued that the petition should not be dismissed because she has met the requirements for the application of equitable tolling. ECF No. 18.

On September 18, 2023, Petitioner contacted chambers via telephone requesting the opportunity to file additional material in response to the motion to dismiss. I granted her request and gave her 30 days to do so. ECF No. 19. Petitioner contacted chambers via telephone on October 25, 2023, requesting additional time to file her response due to technical difficulties. I granted her request. ECF No. 21. On October 30, 2023, Petitioner filed her materials, a 50-page document containing 44 pages of additional argument, contending that her claim should not be dismissed. ECF No. 22 (“Pet’r’s Response”).

This matter is now ripe for a determination as to whether Petitioner’s claim is time barred.

2 II. Summary of Medical Records and Other Fact Evidence

I have provided a brief medical summary concerning the details relevant to the statute of limitations issue in this case. Petitioner filed three PDF documents with excerpts from her medical records. Exs. 1-3.

A. Medical Records

Prior to the allegedly causal flu vaccination, Petitioner’s medical history is remarkable for back and hip pain necessitating physical therapy (“PT”), frozen left shoulder, and neck pain. Ex. 1 at 2. Petitioner also had a history of anxiety and depression that were “[n]ot well controlled” with escitalopram and Xanax. Ex. 2 at 1, 3.

Petitioner received the allegedly causal flu vaccination on November 12, 2019, at the age of 65. Ex. 2 at 1, 4. On November 22, 2019, Petitioner saw Sylvia Emory, MD, complaining of “bilateral leg pain that feels like a nerve pain that starts in her bilateral feet and radiate[s] into the upper legs.” Id. at 5. Petitioner reported that she had had these symptoms off and on for roughly a year, but that they had been “very persistent” for the past month. Id. Dr. Emory ordered blood work. Id.

On December 12, 2019, Petitioner saw Dr. Emory for a follow-up. Ex. 2 at 7. Petitioner stated that she experienced weakness and “a lot of pain” and that she had fallen four times over the past month. Id. Petitioner also complained of numbness and tingling in both hands and feet. Id. Petitioner was hospitalized from December 13 to December 20, 2019, for “painful primary sensory neuropathy.” Ex. 2 at 10. Her discharge paperwork notes that “GBS remains high on the differential.” Id.

On January 3, 2020, Petitioner saw Dr. Emory for a follow-up after her hospitalization. Ex. 2 at 12. Dr. Emory noted that Petitioner underwent “extensive evaluation and workup including neurology consultation” while hospitalized and that Petitioner “was suspected to have a sensory variant of [GBS] with increased protein in [cerebrospinal fluid]. She was treated initially with IVIG and had autonomic variability consistent with peripheral neuropathic disease.” Id. at 13.

On August 11, 2020, Petitioner underwent PT via video conference at which Petitioner reported continuing overall improvements in sensation, endurance, activity tolerance, and balance and that she was able to perform light tasks around her house. Ex. 3 at 4.

On January 6, 2023, Petitioner underwent PT as part of her recovery from GBS and to address a right shoulder injury resulting from a fall “during her [GBS] decline.” Ex. 1 at 10. The record of this appointment includes the comment that Petitioner exhibited “antalgic gait 3 secondary to recovery from [GBS].” Id. at 11.

3 Antalgic gait is “a limp adopted so as to avoid pain on weight-bearing structures (as in hip injuries), characterized by a very short stance phase.” DORLAND’S MEDICAL DICTIONARY ONLINE, https://www.dorlandsonline.com /dorland/definition?id=77912 (last visited Dec. 5, 2023) (“DORLAND’S”). 3 B. Petitioner’s Affidavit

In her affidavit, Petitioner avers that prior to her flu vaccination on November 12, 2019, she was healthy and lived an active lifestyle. Pet. Aff. at 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Irwin v. Department of Veterans Affairs
498 U.S. 89 (Supreme Court, 1991)
Pace v. DiGuglielmo
544 U.S. 408 (Supreme Court, 2005)
Arbas v. Nicholson
403 F.3d 1379 (Federal Circuit, 2005)
Cloer v. Secretary of Health and Human Services
654 F.3d 1322 (Federal Circuit, 2011)
Keeling v. Warden, Lebanon Correctional Inst.
673 F.3d 452 (Sixth Circuit, 2012)
Carson v. Secretary of Health & Human Services
727 F.3d 1365 (Federal Circuit, 2013)
New York and Cuba Mail Steamship Co. v. United States
172 F. Supp. 684 (Court of Claims, 1959)
Checo v. Shinseki
748 F.3d 1373 (Federal Circuit, 2014)
Menominee Indian Tribe of Wis. v. United States
577 U.S. 250 (Supreme Court, 2016)
Holland v. Florida
177 L. Ed. 2d 130 (Supreme Court, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Simmons v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/simmons-v-secretary-of-health-and-human-services-uscfc-2024.